PRISM (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis). Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis - Ebers,G.C. (Lancet, 1998)